Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
Top Cited Papers
- 18 April 2005
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 76 (2-3), 247-265
- https://doi.org/10.1016/j.schres.2005.02.013
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophreniaEuropean Neuropsychopharmacology, 2004
- Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year StudiesAmerican Journal of Psychiatry, 2004
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical AntipsychoticAmerican Journal of Psychiatry, 2003
- Low Incidence of Persistent Tardive Dyskinesia in Elderly Patients With Dementia Treated With RisperidoneAmerican Journal of Psychiatry, 2000
- The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor AnalysisThe Journal of Clinical Psychiatry, 1997
- A placebo‐controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbationActa Psychiatrica Scandinavica, 1990
- A 5-Year Prospective Longitudinal Study of Tardive DyskinesiaJournal of Clinical Psychopharmacology, 1988
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- ParkinsonismNeurology, 1967